论文部分内容阅读
IL-2是由TH细胞分泌的一种淋巴因子。它在肿瘤免疫治疗中的作用,日益受到人们的重视。1988年6月～1989年12月,我院采用南京军区军事医学研究所提供的人IL-2,治疗恶性肿瘤患者66例。现将治疗前后的血液学观察结果报告如下。材料与方法1、病例:66例患者均系经病理检查确诊的中晚期恶性肿瘤。其中男55例,女11例。年龄31岁～71岁。恶性淋巴瘤16例,肺癌19例,胃癌14例,乳腺癌3例,原发性肝癌3例,结肠癌5例,食管癌2例,慢性淋巴细胞白血病、多发性骨髓瘤、膀胱癌及睾丸胚胎性癌各1例。
IL-2 is a lymphokine secreted by TH cells. Its role in tumor immunotherapy has attracted increasing attention. From June 1988 to December 1989, our hospital used the human IL-2 provided by the Nanjing Military Medical Research Institute to treat 66 patients with malignant tumors. Hematology observations before and after treatment are reported below. Materials and Methods 1. Cases: 66 patients were diagnosed with pathological examination of advanced malignant tumors. There were 55 males and 11 females. Age 31 to 71 years old. 16 cases of malignant lymphoma, 19 cases of lung cancer, 14 cases of gastric cancer, 3 cases of breast cancer, 3 cases of primary liver cancer, 5 cases of colon cancer, 2 cases of esophageal cancer, chronic lymphocytic leukemia, multiple myeloma, bladder cancer and testis Embryonic cancer in 1 case.